Skip to content
lifestyle.duovoltart.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
HeartSciences Inc.
HeartSciences Files Definitive Proxy Statement for Proposed Business Combination with Fortitude Mining
October 21, 2026
HeartSciences Receives FDA 510(k) Clearance for its MyoVista® wavECGTM Device
October 6, 2026
HeartSciences Reports Fiscal First Quarter 2027 Financial Results and Provides Business Update
September 15, 2026
Fortitude Invests $1.0 Million in HeartSciences at a 22% Premium with No Adjustment to the Merger Consideration
August 19, 2026
HeartSciences Files Preliminary Proxy Statement for Business Combination with Fortitude Mining Holdings; Provides Business Update and Reports Fiscal 2026 Financial Results
July 29, 2026
HeartSciences Files Its Fiscal 2026 Annual Report on Form 10-K
July 23, 2026
European Patent Granted for ECG-Based Assessment of Diastolic Function, Expands HeartSciences’ Patent Portfolio to More Than 45 Granted Patents
June 11, 2026
HeartSciences Launches MyoVista Insights™ Version 1.3 with AI-ECG Algorithm Marketplace and First FDA-Cleared Algorithm
June 2, 2026
HeartSciences Signs First SaaS Revenues Agreement following full launch of MyoVista Insights™
May 5, 2026